This miRNA targets synaptotagmin-7 (Syt7), a synapse-associated molecule, and it upregulated considerably in multiple sclerosis (MS) lesions, where Syt7 is maldistributed (accumulated in neuronal soma and decreased in axonal structures). The gene discussed is SYT7; the disease is myeloid sarcoma.